PEREGRINE CAPITAL MANAGEMENT LLC Amicus Therapeutics, Inc. Transaction History

PEREGRINE CAPITAL MANAGEMENT LLC portfolio value:

$8.48M
portfolio value

PEREGRINE CAPITAL MANAGEMENT LLC quarter portfolio value change:

-2.79%
quarter

Amicus Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +4.09% 31.95K shares 99K $10.44 812.36K
Q2 2022 share Decrease -5.67% -46.91K shares 547K $10.74 780.40K
Q1 2022 share Decrease -5.42% -47.45K shares -2.26M $9.47 827.32K
Q4 2021 share Increase +23.23% 164.91K shares 3.32M $11.67 874.77K
Q3 2021 share Decrease -1.49% -10.73K shares -167K $9.55 709.85K
Q2 2021 share Increase +4.47% 30.79K shares 131K $9.64 720.58K
Q1 2021 share Increase +2.83% 18.96K shares -8.67M $9.88 689.78K
Q4 2020 share Decrease -31.78% -312.47K shares 1.60M $23.09 670.81K
Q3 2020 share Decrease -0.32% -3.11K shares -991K $14.12 983.29K
Q2 2020 share Decrease -21.72% -273.69K shares 3.23M $15.08 986.41K
Q1 2020 share Increase +0.36% 4.52K shares -586K $9.24 1.26M
Q4 2019 share Increase 0.00% 1.25M shares 12.22M $9.74 1.25M